---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-079176"
form_type: "8-K"
ticker: "CVKD"
cik: "0001937993"
company_name: "Cadrenal Therapeutics, Inc."
filed_at: "2026-07-17T20:15:14+00:00"
generated_at: "2026-07-17T20:16:12.098558+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cadrenal Therapeutics CMO James J. Ferguson III resigns effective July 31, 2026

## Summary
- CMO James J. Ferguson III resigned; effective July 31, 2026.
- Company is conducting a search for replacement.
- Separation agreement includes salary through separation date and COBRA premium payments for 6 months.
- Agreement includes general release of claims and non-disparagement clause.

## SEC filing metadata
- accession: 0001213900-26-079176
- form_type: 8-K
- ticker: CVKD
- cik: 0001937993
- company_name: Cadrenal Therapeutics, Inc.
- filed_at: 2026-07-17T20:15:14+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937993/000121390026079176/0001213900-26-079176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937993/000121390026079176/ea0298082-8k_cadrenal.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-079176
- JSON: https://secwatch.observer/filing/0001213900-26-079176.json
- Plain text: https://secwatch.observer/filing/0001213900-26-079176.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.